跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILASTINA URQUIMA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILASTINA URQUIMA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG
Approved
STANDARD
BILASTINA URQUIMA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG
Urquima S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 24, 2023
Approval ID
9988952211e26ee6
Company
Urquima S.A.
Type
Standard
Approval Details
Approval Id
9988952211e26ee6
Drug Cima Aemps Name
BILASTINA URQUIMA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG
Register Number
88747
Holder Company Name
Urquima S.A.
Marketing Company Name
Urquima S.A.
Authorization Date
2023-03-24
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Urquima S.A.
Active Ingredients
BILASTINA MONOHIDRATO
10,388 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 24, 2023
Approval ID
9988952211e26ee6
Type
Standard
Back to CIMA-AEMPS Approvals